03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Lopimune 133/33mg* : | |
Type | Medicine Non Marketed |
Originator | G |
Agent | Droguerie de l'Union |
Distributor | Droguerie de l'Union |
Laboratory | Cipla |
Responsible Party | Cipla Ltd |
Origin | India |
Manufacturer | Cipla Ltd |
Manufacturing Type | G |
Origin | India |
ATC | J05AR10 |
Lopimune 133/33mg* :
Lopimune 133/33mg* :
Lopimune 133/33mg* :
Lopimune 133/33mg* :
Lopimune 133/33mg* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal distension | Common |
Abdominal pain | Common |
Abdominal pain lower | Common |
Abdominal pain upper | Common |
Abnormal dreams | Uncommon |
Ageusia (Taste loss) | Uncommon |
Alopecia | Uncommon |
ALT increased | Common |
Amenorrhoea (amenorrhea) | Common |
Anaemia | Common |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Common |
Anxiety | Common |
Arteriosclerosis | Uncommon |
Arthralgia (Pain joint) (Joint ache) | Common |
AST increased | Common |
Asthenia | Common |
Atrioventricular block (AVB) | Uncommon |
Autoimmune disorder | Not known |
Back pain | Common |
Basedow's disease | Not known |
Blood creatine phosphokinase increased | Not known |
Blood glucose abnormal | Common |
Body fat disorder | Not known |
Breast enlargement | Not known |
Capillaritis | Uncommon |
Cellulitis | Common |
Cerebrovascular accident | Uncommon |
Cholangitis | Uncommon |
Colitis | Common |
Constipation | Uncommon |
Creatinine renal clearance decreased | Uncommon |
Cushing's syndrome | Not known |
Decreased appetite | Common |
Deep vein thrombosis | Uncommon |
Dermatitis | Common |
Diabetes mellitus | Common |
Diarrhoea (Diarrhea) | Very Common |
Dizziness | Common |
Dry mouth (Xerostomia) | Uncommon |
Duodenitis | Uncommon |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Uncommon |
Dyspepsia | Common |
Eczema | Common |
Erectile dysfunction | Common |
Erythema multiforme | Not known |
Facial wasting | Common |
Faecal incontinence | Uncommon |
Fatigue | Common |
Flatulence | Common |
Folliculitis | Common |
Furuncle | Common |
Gamma-GT increased | Common |
Gastritis | Uncommon |
Gastroduodenal haemorrhage | Uncommon |
Gastroenteritis | Common |
Gastrointestinal ulcer | Uncommon |
Gastrooesophageal reflux disease | Common |
Haematuria (Hematuria) | Uncommon |
Haemorrhoids | Common |
Headache | Common |
Hepatic steatosis | Uncommon |
Hepatitis | Common |
Hepatomegaly | Uncommon |
Hyperbilirubinaemia | Uncommon |
Hypercholesterolaemia | Common |
Hyperglycaemia | Not known |
Hyperlactacidaemia | Not known |
Hypersensitivity | Common |
Hypertension | Common |
Hypertriglyceridaemia | Common |
Hypogonadism | Uncommon |
Immune reconstitution inflammatory syndrome | Uncommon |
Increased appetite | Uncommon |
Insomnia | Common |
Insulin resistance | Not known |
Jaundice | Not known |
Leucopenia (Leukopenia) | Common |
Libido decreased | Uncommon |
Lipodystrophy acquired | Common |
Lipohypertrophy | Not known |
Lower respiratory tract infection | Common |
Lymphadenopathy | Common |
Maculopapular rash | Common |
Menorrhagia | Common |
Menstrual disorder | Common |
Metabolic disorder | Not known |
Migraine | Common |
Mouth ulceration | Uncommon |
Muscle disorder | Common |
Muscle spasms | Common |
Muscle weakness | Common |
Musculoskeletal pain | Common |
Myalgia | Common |
Myocardial infarction | Uncommon |
Myositis | Not known |
Nausea | Very Common |
Nephritis | Uncommon |
Neuropathy peripheral | Common |
Neutropenia | Common |
Night sweats | Common |
Osteonecrosis | Uncommon |
Pancreatitis | Common |
Pruritus | Common |
Rectal haemorrhage | Uncommon |
Rhabdomyolysis | Uncommon |
Seborrhoeic dermatitis | Common |
Seizures | Uncommon |
Skin infection | Common |
Skin rash | Common |
Stevens-Johnson syndrome | Not known |
Stomatitis | Uncommon |
Tinnitus | Uncommon |
Tremor | Uncommon |
Tricuspid valve incompetence | Uncommon |
Upper respiratory tract infection | Very Common |
Urticaria | Common |
Vasculitis | Uncommon |
Vertigo | Uncommon |
Visual disturbance | Uncommon |
Vomiting | Common |
Weight decreased (Weight loss) | Common |
Weight increased (weight gain) | Uncommon |
NB : Products With Same Indication |
Different Units By MoH Code
Lopimune 133/33mg* MoH 5167 :
Form | Capsule, hard |
Package Size | Box of 90 |
Strength | 133/33mg |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 222239/07 |
Submission date | 01/01/2007 |
Registration Year | 2007 |
Archived Date | 2019 |
Price Comparison
You have to register to view this info
Drop File